W
WAVEMAN · COMPANY
RTB · Rtb Digital, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

RTB

RTB Digital, Inc.
PHARMA & BIOTECH · SERVICES-MANAGEMENT CONSULTING SERVICES · CIK 0001419275
ACTIVIST 13D☆ WATCH
INSIDER NET · 180D
-
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
12
13F, latest reported quarter
REVENUE GROWTH
-38.7%
XBRL, annual
NET MARGIN
-157.5%
CONVERSIONS · 180D
1
codes C/M, not in net · $275.7K priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
no Form 4 purchases or sales on file
CONGRESS
no member of Congress has reported trading it
FUNDS
12 funds added or opened last quarter
below 79% of Pharma & Biotech
REVENUE
-38.7% year over year
below 80% of Pharma & Biotech
MARGIN
-157.5% net margin
below 69% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Comer James Lamar Walton disclosed a 5%+ stake (31.7%) in the last six months.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +12.0%
+12.0%12M
-69%-20%+29%+78%2025-092025-102025-122026-032026-052026-072026-09 2026-06-26 · Comer James Lamar Walton filed a 5%+ stake (31.7%)
13D/G STAKE
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
An activist crossed the 5% line with declared intent.
The record shows 12 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for RTB Digital, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE

no insider purchases or sales on record

0 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
ARMISTICE CAPITAL, LLC
350,000.0 sh
$5.3M
GEODE CAPITAL MANAGEMENT, LLC
156,876.0 sh
$2.4M
STATE STREET CORP
44,979.0 sh
$678.3K
MILLENNIUM MANAGEMENT LLC
41,939.0 sh
$632.4K
BlackRock, Inc.
31,587.0 sh
$476.3K
5%+ owners
13D = intent to influence · 13G = passive
Comer James Lamar Walton
ACTIVIST 13D · 2026-06-26
31.7%
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Fidelity Extended Market Index Fund
$40.1K POSITION · AS OF 2026-02-28
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$37.0K POSITION · AS OF 2026-03-31
0.0%
Fidelity Series Total Market Index Fund
$5.0K POSITION · AS OF 2026-02-28
0.0%
Fidelity Nasdaq Composite Index Fund
$435 POSITION · AS OF 2026-02-28
0.0%
Fidelity Total Market Index Fund
$1.5K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$11.1M$18.2M$65.9M$32.9M
GROSS PROFIT$5.3M$7.4M$25.7M$16.1M
OPERATING INCOME$-13.1M$-27.2M$-12.3M$-37.8M
NET INCOME$-17.5M$-26.8M$-53.1M$-49.2M
EPS (DILUTED)-29.33-140.25-10.11
OPERATING CASH FLOW$-23.0M$21.2M$33.2M$-9.3M
CASH$7.4M$2.6M$12.2M$14.0M
LONG-TERM DEBT$17.4M$15.9M$61.7M
BUYBACKS$0
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →